Edition:
United Kingdom

AcelRx Pharmaceuticals Inc (ACRX.OQ)

ACRX.OQ on NASDAQ Stock Exchange Global Market

2.95USD
15 Aug 2018
Change (% chg)

-- (--)
Prev Close
$2.95
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
77,878
52-wk High
$5.75
52-wk Low
$1.58

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.22 December 16 Aug 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 3 3 3 2
(3) HOLD 3 3 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.50 2.50 2.40 2.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 5 0.97 2.30 0.00 17.79
Quarter Ending Dec-18 5 3.09 8.50 0.00 12.59
Year Ending Dec-18 6 5.69 11.00 1.00 29.70
Year Ending Dec-19 6 20.51 30.60 9.10 67.89
Earnings (per share)
Quarter Ending Sep-18 6 -0.22 -0.18 -0.25 -0.05
Quarter Ending Dec-18 6 -0.21 -0.14 -0.28 -0.17
Year Ending Dec-18 5 -0.83 -0.77 -0.86 -0.83
Year Ending Dec-19 6 -0.77 -0.58 -1.00 -0.29

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 0.91 0.82 0.09 10.11
Quarter Ending Mar-18 1.15 0.34 0.81 70.17
Quarter Ending Dec-17 5.25 0.74 4.51 85.90
Quarter Ending Sep-17 2.22 1.49 0.73 32.88
Quarter Ending Jun-17 2.27 2.66 0.39 17.28
Earnings (per share)
Quarter Ending Jun-18 -0.20 -0.20 0.00 -0.84
Quarter Ending Mar-18 -0.24 -0.23 0.01 -3.16
Quarter Ending Dec-17 -0.20 -0.20 0.00 -1.68
Quarter Ending Sep-17 -0.27 -0.28 0.01 -4.36
Quarter Ending Jun-17 -0.28 -0.29 0.01 -2.95

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 0.97 0.97 2.43 2.84 17.79
Quarter Ending Dec-18 3.09 3.09 1.31 1.64 12.59
Year Ending Dec-18 5.69 5.69 5.50 6.44 29.70
Year Ending Dec-19 20.51 20.51 20.14 21.81 67.89
Earnings (per share)
Quarter Ending Sep-18 -0.22 -0.22 -0.19 -0.21 -0.05
Quarter Ending Dec-18 -0.21 -0.21 -0.22 -0.25 -0.17
Year Ending Dec-18 -0.83 -0.83 -0.83 -0.89 -0.83
Year Ending Dec-19 -0.77 -0.77 -0.74 -0.79 -0.29

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 1 2
Quarter Ending Dec-18 0 0 2 1
Year Ending Dec-18 0 0 3 2
Year Ending Dec-19 0 0 2 0
Earnings
Quarter Ending Sep-18 0 0 2 3
Quarter Ending Dec-18 0 0 2 2
Year Ending Dec-18 0 0 3 1
Year Ending Dec-19 0 0 3 2